Documente Academic
Documente Profesional
Documente Cultură
yrsBS0Qgi E5NgMAAAA
AAAFihJbn UV9MQVNUU
VU1RPTV9CRVRBAQAAAEpSDwAC
RVRBAQAAAEpSDwACAAAAEDEuOTkxOTc2NDI3Mzc4NjMAFGrgrsBS0QiXHfKuwFLRCCJDSVEuTllTRTpFTUUuSVF
SVEuTllTRTpFTUUuSVFfVE9UQUxfREVCVC5GWSAyMDEzAQAAAG5tAAACAAAABzM1NC42NjMBCAAAAAUAAAA
2NjMBCAAAAAUAAAABMQEAAAAKMTY2MDIzMTQzOAMAAAADMTYwAgAAAAQ0MTczBAAAAAEwBwAAAAk2LzE
AAAAEwBwAAAAk2LzEwLzIwMTQIAAAACjEyLzMxLzIwMTMJAAAAATAUauCuwFLRCIb28a7AUtEIEENJUS5OQVNE
AUtEIEENJUS5OQVNEQVFHUzpTUC4FAAAAAQAAAAgAAAAWKEludmFsaWQgRm9ybXVsYSBOYW1lKXWukLrAU
YSBOYW1lKXWukLrAUtEIiwafusBS0QgkQ0lRLk5ZU0U6RU1FLklRX1RPVEFMX0FTU0VUUy5GWSAyMDEzAQAAAG
5GWSAyMDEzAQAAAG5tAAACAAAACDM0NjUuOTE1AQgAAAAFAAAAATEBAAAACjE2NjAyMzE0MzgDAAAAAzE2
MzE0MzgDAAAAAzE2MAIAAAAEMTAwNwQAAAABMAcAAAAJNi8xMC8yMDE0CAAAAAoxMi8zMS8yMDEzCQAAA
Mi8zMS8yMDEzCQAAAAEwFGrgrsBS0QinRPKuwFLRCCRDSVEuTkFTREFRR1M6U1AuSVFfRVFVSVRZX0FQLkZZID
RVFVSVRZX0FQLkZZIDIwMTMBAAAA3dUBAAIAAAAFMC4wMjIBCwAAAAUAAAACMTMBAAAABzQ5MzYzNTYDAA
AAABzQ5MzYzNTYDAAAABTQxNzA5BAAAAAU0MTYzNwIAAAAHMzAwOTcyNgYAAAAHMjE1MDMyMQcAAAABMA
1MDMyMQcAAAABMAgAAAADMTYwCQAAAAU0MTYzNwoAAAABMAsAAAACNDYUauCuwFLRCHbP8a7AUtEIDU
FLRCHbP8a7AUtEIDUNJUS5OWVNFOkVNRS4FAAAAAQAAAAgAAAAWKEludmFsaWQgRm9ybXVsYSBOYW1lKXW
9ybXVsYSBOYW1lKXWukLrAUtEIet+eusBS0Qg=
Exhibit 1 Landmark's Simplified Financial Statements, 2010-2014 (U.S. $ millions)
2010 2011 2012 2013 2014 [E]
Income statement
Net sales 289.9 304.1 316.4 329.0 345.5
COGS 259.4 273.1 284.1 295.3 310.4
Gross profit 30.5 31.0 32.3 33.7 35.1
Operating expenses 20.9 21.6 26.7 28.6 30.3
Depreciation and amortization 1.6 1.6 1.7 1.7 1.8
Operating profit 8.0 7.8 3.9 3.4 3.0
Interest expense 0.0 0.0 0.3 0.2 0.0
Income taxes 2.8 2.7 1.3 1.1 1.1
Net income 5.2 5.1 2.3 2.1 2.0
EPS $1.30 $1.27 $0.58 $0.52 $0.49
Dividend $0.20 $0.20 $0.20 $0.20 $0.20
Balance sheet
Cash 3.6 4.2 3.3 1.5 0.4
Accounts receivable 20.7 22.0 29.3 30.4 31.0
Other current assets 6.3 5.1 4.9 5.0 4.9
Current assets 30.6 31.3 37.5 36.9 36.3
Net PP&E 3.1 5.1 7.2 9.2 11.2
Investments and other assets 45.0 47.1 47.3 47.6 47.2
Total assets 78.7 83.6 92.0 93.7 94.6
Balance sheet
Cash 1.8 1.0 1.9 1.5 2.1
Accounts receivable 13.1 13.5 14.6 15.2 16.2
Other current assets 2.8 4.0 4.1 4.2 4.2
Current assets 17.7 18.5 20.6 20.9 22.5
Net PP&E 16.0 17.4 18.6 19.7 20.9
Investments and other assets 35.9 38.6 41.8 43.2 43.5
Total assets 69.6 74.5 81.1 83.8 86.8
Exhibit 3b Five-year Forecast of Broadway's Income and Cash Flow, 2015-2019 (U.S. $ millions)*
2015 2016 2017 2018 2019
Net sales 168.4 175.1 182.1 189.4 197.0
Operating profit 6.7 7.0 7.3 7.6 7.9
Interest expense 0.4 0.4 0.4 0.4 0.4
Net income 4.1 4.3 4.5 4.7 4.9
Depreciation and amortization 3.1 3.3 3.5 3.7 3.9
Change in net working capital 0.4 0.4 0.4 0.4 0.4
Capital expenditure 4.2 4.4 4.6 4.7 4.9
Total FCF 2.8 3.1 3.3 3.5 3.7
*Numbers in the exhibits are based on the assumption Broadway does not acquire Landmark.
Exhibit 4 Financial Data of Publically Traded Competitors, 2014 (U.S. $ millions)
Comparable Company 1 Comparable Company 2
Sales $13,945.7 $6,417.2
Net income $219.4 $123.8
EPS $0.95 $1.84
$22.73
22.0
$500.1
$289.0
$862.4
1.56
57.8%
1.134
Exhibit 5 Selected Capital Markets Information as of September 1, 2014
Treasury:
3-month Treasury bill rate 0.04%
1-year Treasury bond rate 0.10%
10-year Treasury bond rate 2.56%
Landmark
2015 2016 2017 2018 2019
Net sales 362.8 380.9 400.0 420.0 441.0
Operating profit 5.4 5.7 6.0 6.3 6.6
Net income 3.5 3.7 3.9 4.1 4.3
Depreciation and amortization 2.1 2.4 2.7 3.0 3.3
Change in net working capital 1.3 1.3 1.4 1.5 1.6
Capital expenditure 3.6 3.8 4.0 4.2 4.4
Total FCF 0.7 1.0 1.2 1.4 1.6
EV 71.0812897523
$51.85 0.7 1.0 1.2 1.4 72.7
Bradway
2015 2016 2017 2018 2019
Net sales 168.4 175.1 182.1 189.4 197.0
Operating profit 6.7 7.0 7.3 7.6 7.9
Interest expense 0.4 0.4 0.4 0.4 0.4
Net income 4.1 4.3 4.5 4.7 4.9
Depreciation and amortization 3.1 3.3 3.5 3.7 3.9
Change in net working capital 0.4 0.4 0.4 0.4 0.4
Capital expenditure 4.2 4.4 4.6 4.7 4.9
Total FCF 2.8 3.1 3.3 3.5 3.7
EV 110.2
$86.31 2.8 3.1 3.3 3.5 113.9
$138.16
*Forcast the sith year and match Depr and amort for perpetuity otherwise you run out of money!!
2020 2015 2016 2017 2018 2019
458.6 Net sales 362.8 380.9 400.0 420.0 441.0
6.9 Operating profit 5.4 7.6 10.0 12.6 13.2
4.5 Net income 3.5 5.0 6.5 8.2 8.6
3.6 Depreciation and 2.1 2.4 2.7 3.0 3.3
1.3 Change in net wo -0.1 -0.6 0.4 0.0 -0.9
3.6 Capital expendit 3.6 3.8 4.0 4.2 4.4
3.2 Total FCF 2.12 4.18 4.76 6.99 8.43
EV 178.934724703
$139.16 2.1 4.2 4.8 7.0 187.4
$251.47
Exhibit 3b Five-year Forecast of Broadway's Income and Cash Flow, 2015-2019 (U.S. $ millions)*
2015 2016 2017 2018 2019
Net sales 168.4 175.1 182.1 189.4 197.0
Operating profit 6.7 7.0 7.3 7.6 7.9
Interest expense 0.4 0.4 0.4 0.4 0.4
Net income 4.1 4.3 4.5 4.7 4.9
Depreciation and amortization 3.1 3.3 3.5 3.7 3.9
Change in net working capital 0.4 0.4 0.4 0.4 0.4
Capital expenditure 4.2 4.4 4.6 4.7 4.9
Total FCF 2.8 3.1 3.3 3.5 3.7
*Numbers in the exhibits are based on the assumption Broadway does not acquire Landmark.
2010
1.70
40.78
40.78
53.91
53.91
3.8432658067
Exhibit 3a Five-year Forecast of Landmark's Income and Cash Flow, 2015-2019 (U.S. $ millions)*
2015 2016 2017 2018 2019
Net sales 362.8 380.9 400.0 420.0 441.0
Operating profit 5.4 7.6 10.0 12.6 13.2
Net income 3.5 5.0 6.5 8.2 8.6
Depreciation and amortization 2.1 2.4 2.7 3.0 3.3
Change in net working capital -0.1 -0.6 0.4 0.0 -0.9
Capital expenditure 3.6 3.8 4.0 4.2 4.4
Total FCF 2.12 4.18 4.76 6.99 8.43
Terminal Value a
Cafh flow A 6.39 8.48 8.43 10.98 12.78
NPV all debt financing 242.12
Terminal Value b
Cafh flow B 6.39 8.48 8.43 10.98 12.78
NPV all debt financing 50/50 325.27
Exhibit 3b Five-year Forecast of Broadway's Income and Cash Flow, 2015-2019 (U.S. $ millions)*
2015 2016 2017 2018 2019
Net sales 145.7 131.1 142.9 155.8 169.8
Operating profit 9.5 9.2 10.7 11.7 12.7
Interest expense 0.4 0.4 0.4 0.4 0.4
Net income 5.9 5.7 6.7 7.3 8.0
Depreciation and amortization 3.1 3.3 3.5 3.7 3.9
Change in net working capital -0.8 -0.8 0.6 0.7 0.7
Capital expenditure 2.9 2.6 2.9 3.1 3.4
Total FCF 7.1 7.4 7.0 7.5 8.0
*Numbers in the exhibits are based on the assumption Broadway does not acquire Landmark.
13.75
329.49
329.49
435.54
435.54
176.6219603522
13.2
0.4
8.4
4.1
0.4
3.5
8.8
5.0
Exhibit 3a Five-year Forecast of Landmark's Income and Cash Flow, 2015-2019 (U.S. $ millions)*
2015 2016 2017 2018 2019
Net sales 362.8 380.9 400.0 420.0 441.0
Operating profit 5.4 7.6 10.0 10.5 11.0
Net income 3.5 5.0 6.5 6.8 7.2
Depreciation and amortization 2.1 2.4 2.7 3.0 3.3
Change in net working capital -0.1 1.3 1.3 -0.7 1.4
Capital expenditure 3.6 3.8 4.0 4.2 4.4
Total FCF 2.12 2.27 3.87 6.32 4.69
Terminal Value a
Cafh flow A 6.28 5.85 6.04 9.46 7.69
NPV all debt financing 152.68
Terminal Value b
Cafh flow B 6.28 5.85 6.04 9.46 7.69
NPV all debt financing 50/50 203.35
Exhibit 3b Five-year Forecast of Broadway's Income and Cash Flow, 2015-2019 (U.S. $ millions)*
2015 2016 2017 2018 2019
Net sales 137.6 117.0 126.3 136.4 147.4
Operating profit 8.4 7.1 7.7 9.6 9.7
Interest expense 0.4 0.4 0.4 0.4 0.4
Net income 5.2 4.4 4.7 5.9 6.1
Depreciation and amortization 3.1 3.3 3.5 3.7 3.9
Change in net working capital -1.2 -1.1 0.5 0.5 0.6
Capital expenditure 2.8 2.3 2.5 2.7 2.9
Total FCF 7.0 6.7 5.5 6.6 6.7
*Numbers in the exhibits are based on the assumption Broadway does not acquire Landmark.
8.35
200.26
200.26
264.72
264.72
152.5
10.1
0.4
6.3
4.1
0.3
3.1
7.3
3.5